Market Overview

Buckingham Research Downgrades Teva Pharmaceutical Industries Limited to Neutral, Removes $56 P

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TEVA

DateFirmActionFromTo
Aug 2016Leerink SwannMaintainsOutperform
Aug 2016BTIG ResearchMaintainsBuy
Jul 2016HSBCUpgradesHoldBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (TEVA)